Alnylam Pharmaceuticals Inc. drawdown: 66.4% below the all-time high (price)
Alnylam Pharmaceuticals Inc. is 66.4% below its all-time high, set Oct 20, 2025 (as of market close, Nov 13, 2026), measured on price alone — dividends are not included, the convention headlines and crash histories use. The chart shows every day as a percentage of the highest level reached up to that point: 100% means a fresh record, everything below is a drawdown.
- Below all-time high
- −66.4%
- 33.6% of ATH
- All-time high
- $491.22
- Oct 20, 2025
- Time below the high
- 13 mo
- since Oct 20, 2025
- Worst-ever drawdown
- −83.6%
- Oct 3, 2011
- Longest underwater
- 5.7 yrs
- between all-time highs
- Today's level first reached
- Jul 20, 2020
- 6.3 yrs ago
- Last time this deep
- Feb 23, 2017
- in a previous episode
% of all-time high since 2004: price#
The classic underwater chart (drawdown curve), drawn as % of the all-time high — 100% is a fresh record, everything below it is time spent underwater. Basis and range are in the URL, so a particular view is a link.
The deepest drawdowns on record#
Data provided bySource: Twelve DataEvery decline of 15% or more from an all-time high (price basis), deepest first.
| Peak | Trough | Depth | Peak → trough | Recovered by | Underwater |
|---|---|---|---|---|---|
| Oct 9, 2007 | Oct 3, 2011 | −83.6% | 4.0 yrs | Jul 3, 2013 | 5.7 yrs |
| Jun 22, 2015 | Nov 3, 2016 | −77.4% | 16 mo | Nov 10, 2017 | 2.4 yrs |
| Oct 20, 2025 | Nov 10, 2026 | −69.1% | 13 mo | not yet | 13 mo+ |
| Mar 20, 2018 | Dec 24, 2018 | −57.8% | 9 mo | Jun 19, 2020 | 2.3 yrs |
| Jun 9, 2004 | Aug 16, 2004 | −52.2% | 2 mo | Jan 6, 2005 | 7 mo |
| Jan 13, 2014 | Apr 28, 2014 | −47.6% | 3 mo | Oct 24, 2014 | 9 mo |
| Oct 14, 2021 | May 11, 2022 | −42.5% | 7 mo | Aug 3, 2022 | 10 mo |
| Dec 21, 2022 | Apr 26, 2024 | −40.6% | 16 mo | Jun 26, 2024 | 1.5 yrs |
Price basis (no dividends) — the convention crash histories use. With dividends reinvested, recoveries arrive years earlier; switch the basis on the chart above to see it.
Drawdown vs what came next#
Data provided bySource: Twelve DataOne dot per month since 2004: how far Alnylam Pharmaceuticals Inc. stood below its all-time high, and the total return over the following 1, 5 and 10 years.
Read this with survivorship bias in mind: a single asset's history is one surviving sample, so past recoveries here say little about the odds ahead. Monthly windows also overlap heavily (they are not independent samples). Not investment advice.
FAQ#
- How far is Alnylam Pharmaceuticals Inc. from its all-time high?
- Alnylam Pharmaceuticals Inc. is currently 66.4% below its all-time high, set Oct 20, 2025 (as of market close, Nov 13, 2026). Prices only, the convention headlines use; with dividends reinvested the gap is usually smaller.
- What was the biggest Alnylam Pharmaceuticals Inc. drawdown ever?
- The deepest decline on record in our data (since 2004) took Alnylam Pharmaceuticals Inc. 83.6% below its prior high, bottoming Oct 3, 2011. The table on this page lists every major episode with its peak, trough and recovery date.
Methodology & related#
Daily data since 2004 from ALNY; no free deep history exists for Alnylam Pharmaceuticals Inc. — for a 150-year drawdown record see the S&P 500 drawdown page. The price basis excludes dividends; the total-return basis reinvests them; the real basis additionally deflates by CPI. See also returns by year. Past performance does not predict future returns; not investment advice.